SCHEMBL26088331

SCHEMBL26088331

Cn1c(=O)cc(N)c2cc(C(F)(F)F)cc(Cl)c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 10/20 0.36
GABRD O14764 10/20 0.36
GABRA1 P14867 10/20 0.36
GABRB1 P18505 10/20 0.36
GABRG2 P18507 10/20 0.36
GABRB3 P28472 10/20 0.36
GABRA5 P31644 10/20 0.36
GABRA3 P34903 10/20 0.36
GABRA2 P47869 10/20 0.36
GABRB2 P47870 10/20 0.36
GABRA4 P48169 10/20 0.36
GABRE P78334 10/20 0.36
GABRA6 Q16445 10/20 0.36
GABRG1 Q8N1C3 10/20 0.36
GABRG3 Q99928 10/20 0.36
GABRQ Q9UN88 10/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP3A4 P08684 1/20 0.35
CD38 P28907 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29837238 1.00 GABRP (0.36) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL23689989 0.77 MAT2A (0.40) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL31204111 0.73 TNKS (0.37) PKMPKLRMEN1KMT2ADDR1
SCHEMBL25276159 0.73 TNKS (0.37) PKMPKLRMEN1KMT2ADDR1
SCHEMBL25232301 0.71 DDR1 (0.36) PKMPKLRMEN1KMT2ADDR1
SCHEMBL25229534 0.71 IKBKE (0.38) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL31172135 0.71 DDR1 (0.36) PKMPKLRMEN1KMT2ADDR1
SCHEMBL31172192 0.71 IKBKE (0.38) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8890432 0.70 GABRA2 (0.43) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL31172148 0.70 GABRP (0.44) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230131903-A1 PESTICIDALLY ACTIVE FUSED BICYCLIC HETEROAROMATIC COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2023-04-27 US disclosed
US-20230131903-A1 PESTICIDALLY ACTIVE FUSED BICYCLIC HETEROAROMATIC COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2023-04-27 US disclosed
US-20230131903-A1 PESTICIDALLY ACTIVE FUSED BICYCLIC HETEROAROMATIC COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2023-04-27 US disclosed
CN-115023420-A Pesticidally active fused bicyclic heteroaromatic compounds 先正达农作物保护股份公司 2022-09-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230131903-A1 PESTICIDALLY ACTIVE FUSED BICYCLIC HETEROAROMATIC COMPOUNDS DDT, ACHE, GSTO1 GABRP 390/4885GABRD 324/4885GABRA1 385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.